In addition, in several cancer cells, an abnormally low NADPH/NADP+ ratio has been reported [56,57,58]; this suggests the recovery of cell reducing power as a primary necessity for tumor cells, often linked to IDH mutations frequently observed in glioma cells. The gene discussed is IDH1; the disease is glioma.